SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $27,000 | +12.5% | 105,798 | +1.3% | 0.00% | – |
Q1 2016 | $24,000 | -85.1% | 104,420 | -77.4% | 0.00% | – |
Q4 2015 | $161,000 | +109.1% | 461,700 | +926.8% | 0.00% | – |
Q3 2015 | $77,000 | +60.4% | 44,967 | +105.9% | 0.00% | – |
Q2 2015 | $48,000 | -91.6% | 21,836 | -92.6% | 0.00% | – |
Q1 2015 | $573,000 | -42.4% | 295,726 | -21.3% | 0.00% | -100.0% |
Q4 2014 | $994,000 | -13.0% | 375,726 | -1.1% | 0.00% | 0.0% |
Q3 2014 | $1,142,000 | -39.9% | 380,056 | -18.3% | 0.00% | 0.0% |
Q2 2014 | $1,901,000 | -9.5% | 465,237 | -4.6% | 0.00% | 0.0% |
Q1 2014 | $2,101,000 | -38.5% | 487,875 | -25.2% | 0.00% | -50.0% |
Q4 2013 | $3,416,000 | -27.4% | 652,298 | -12.6% | 0.00% | -33.3% |
Q3 2013 | $4,704,000 | – | 746,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
CAXTON CORP | 57,000 | $99,000 | 0.13% |
Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |